These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 5569040

  • 1. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G, Frederiksen G.
    Ugeskr Laeger; 1971 Jul 23; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract] [Full Text] [Related]

  • 2. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S, Samuelson G, Sjölin S.
    Pediatrics; 1970 Feb 23; 45(2):260-8. PubMed ID: 5413388
    [No Abstract] [Full Text] [Related]

  • 3. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971 Feb 23; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 4. [Functional disorders of the renal tubules in Wilson's disease].
    Holl H, Troelstra JA.
    Ned Tijdschr Geneeskd; 1968 Nov 30; 112(48):2184-8. PubMed ID: 5704622
    [No Abstract] [Full Text] [Related]

  • 5. [Penicillamine treatment of Wilson's disease].
    Falkmer S, Samuelson G, Sjölin S.
    Lakartidningen; 1969 May 14; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract] [Full Text] [Related]

  • 6. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B, el-Kamel M.
    Tunis Med; 1974 May 14; 52(1):29-31. PubMed ID: 4215182
    [No Abstract] [Full Text] [Related]

  • 7. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC.
    J Lab Clin Med; 2003 Jun 14; 141(6):372-7. PubMed ID: 12819634
    [Abstract] [Full Text] [Related]

  • 8. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J, Brandt G.
    Med Welt; 1981 Jan 16; 32(3):109-10. PubMed ID: 7207132
    [No Abstract] [Full Text] [Related]

  • 9. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L, Campanella G, D'Addabbo A.
    Acta Neurol (Napoli); 1971 Jan 16; 26(4):423-35. PubMed ID: 5132824
    [No Abstract] [Full Text] [Related]

  • 10. [Hepatolenticular degeneration. Wilson's disease].
    Hansen HJ, Andersen OS.
    Ugeskr Laeger; 1969 Jul 31; 131(31):1301-5. PubMed ID: 4898805
    [No Abstract] [Full Text] [Related]

  • 11. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R, Marazzi MG, Barabino A, Fasce L, Ciravegna B, Famularo L, Boni L, Callea F.
    Ital J Gastroenterol Hepatol; 1997 Apr 31; 29(2):155-61. PubMed ID: 9646197
    [Abstract] [Full Text] [Related]

  • 12. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, Mabuchi H, Kono S, Miyajima H.
    Am J Gastroenterol; 2001 Nov 31; 96(11):3147-51. PubMed ID: 11721763
    [Abstract] [Full Text] [Related]

  • 13. Neuropathological findings in penicillamine-treated patients with Wilson's disease.
    Horoupian DS, Sternlieb I, Scheinberg IH.
    Clin Neuropathol; 1988 Nov 31; 7(2):62-7. PubMed ID: 3390974
    [Abstract] [Full Text] [Related]

  • 14. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G, Pépin B, Milhaud M, Jérome H, Pacilly A.
    Rev Neurol (Paris); 1968 Jan 31; 118(1):27-35. PubMed ID: 5697565
    [No Abstract] [Full Text] [Related]

  • 15. [Wilson's disease (hepatocerebral degeneration)].
    Sternlieb I.
    Internist (Berl); 1976 Jul 31; 17(7):342-7. PubMed ID: 780309
    [No Abstract] [Full Text] [Related]

  • 16. [True hepatic Wilson's disease].
    Ciravegna B, Giacchino R, Marazzi MG.
    Pediatr Med Chir; 1983 Jul 31; 5(1-2):7-10. PubMed ID: 6634446
    [Abstract] [Full Text] [Related]

  • 17. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb 31; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

  • 18. Ocular manifestations of Wilson's disease in Iran.
    Kashani AA.
    Trans Ophthalmol Soc U K (1962); 1977 Apr 31; 97(1):18-9. PubMed ID: 271391
    [Abstract] [Full Text] [Related]

  • 19. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
    Lange J.
    Dtsch Med Wochenschr; 1967 Sep 15; 92(37):1657-62. PubMed ID: 6054323
    [No Abstract] [Full Text] [Related]

  • 20. Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study.
    Sternlieb I, Feldmann G.
    Gastroenterology; 1976 Sep 15; 71(3):457-61. PubMed ID: 950097
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.